Primary Membranous Nephropathy Clinical Trial
Official title:
A Phase III Randomized, Open-Label Active Comparator-Controlled Multicenter Study to Evaluate Efficacy and Safety of Obinutuzumab in Patients With Primary Membranous Nephropathy
This study will evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics (PK) of obinutuzumab compared with tacrolimus in participants with primary membranous nephropathy (pMN).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05800873 -
Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001
|
Phase 1 | |
Recruiting |
NCT05514015 -
Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy
|
Phase 4 | |
Recruiting |
NCT05668403 -
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
|
Phase 1 | |
Recruiting |
NCT05696613 -
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
|
Phase 3 | |
Recruiting |
NCT05862233 -
A Clinical Study of MIL62 in Primary Membranous Nephropathy
|
Phase 3 | |
Not yet recruiting |
NCT06466135 -
Study of WAL0921 in Patients With Glomerular Kidney Diseases
|
Phase 2 | |
Not yet recruiting |
NCT06120673 -
REmission in Membranous Nephropathy International Trial (REMIT)
|
Phase 3 | |
Recruiting |
NCT05398653 -
A Clinical Study of MIL62 in Primary Membranous Nephropathy
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05136456 -
Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy
|
Phase 2 | |
Recruiting |
NCT05707377 -
A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy
|
Phase 2/Phase 3 |